Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff ...

Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...

The once-daily pill combines Opko’s long-acting GLP-1/glucagon dual agonist peptide, dubbed OPK-88006, with Entera’s N-Tab ...

“Whether consumers are using GLP-1 medications for weight management or are reducing sugar intake as part of their overall ...

And it could work for weight-loss drugs like Wegovy and Ozempic, or commonly used biological drugs like Humira, prescribed for rheumatoid arthritis. A 2024 study from Beth Israel Deaconess Medical ...

In January, The Wall Street Journal derided Trump’s threat to impose 25 percent tariffs on Canada and Mexico as the opening ...

The message is clear: if you want access to US markets, you must be willing to strike what President Trump considers a fair ...

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday. The update about the popular semaglutide injections ...

Novo Nordisk is cutting the cost of its blockbuster weight-loss drug Wegovy in half for U.S. patients paying cash through its direct-to-patient online pharmacy, as competition in the highly ...

For eligible patients, health care providers can send Wegovy prescriptions directly to NovoCare Pharmacy. Novo Nordisk is providing direct-to-patient delivery of Wegovy ® (semaglutide ...

The Food and Drug Administration announced Friday it had officially declared an end to the nationwide shortage of Ozempic and Wegovy, medications used for diabetes and weight loss. The agency ...